Who Says You Can’t Have It All
Summary
July 29, 2025
Next-generation sequencing (NGS) has transformed the landscape of hematological malignancy testing, yet challenges remain in achieving comprehensive, rapid and actionable results.
Join the Association for Molecular Pathology for a free webinar featuring speaker Sean Glenn, PhD, of the Roswell Park Comprehensive Cancer Center. Dr. Glenn was a co-developer of the SureSelect Cancer Pan Heme Assay, a novel hybridization-capture assay that detects mutations across hundreds of genes for all hematologic malignancies in under 72 hours.
Register for this webinar.
Join the Association for Molecular Pathology for a free webinar featuring speaker Sean Glenn, PhD, of the Roswell Park Comprehensive Cancer Center. Dr. Glenn was a co-developer of the SureSelect Cancer Pan Heme Assay, a novel hybridization-capture assay that detects mutations across hundreds of genes for all hematologic malignancies in under 72 hours.
Register for this webinar.